Idexx Laboratories (IDXX) came out with quarterly earnings of $3.63 per share, beating the Zacks Consensus Estimate of $3.31 per share. This compares to earnings of $2.44 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of +9.67%. A quarter ago, it was expected that this Animal diagnostic and health care company would post earnings of $2.92 per share when it actually produced earnings of $2.96, delivering a surprise of +1.37%. Ov ...

Group 1 - Piper Sandler Companies reported quarterly earnings of $2.95 per share, exceeding the Zacks Consensus Estimate of $1.99 per share, and showing an increase from $2.52 per share a year ago, resulting in an earnings surprise of +48.24% [1] - The company achieved revenues of $405.39 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 17.61%, compared to $339.18 million in the same quarter last year [2] - Piper Sandler Companies has outperformed consensus EPS estimates in all four of the last quarters [2] Group 2 - The stock has increased approximately 5.1% since the beginning of the year, while the S&P 500 has gained 7.8% [3] - The company's earnings outlook is crucial for investors, as it includes current consensus earnings expectations for upcoming quarters and any recent changes to those expectations [4] - The current consensus EPS estimate for the upcoming quarter is $2.92 on revenues of $406.9 million, and for the current fiscal year, it is $12.75 on revenues of $1.6 billion [7] Group 3 - The Financial - Investment Bank industry, to which Piper Sandler belongs, is currently ranked in the top 7% of over 250 Zacks industries, indicating a favorable outlook [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5] - The estimate revisions trend for Piper Sandler was mixed prior to the earnings release, resulting in a Zacks Rank 3 (Hold) for the stock, indicating expected performance in line with the market [6]

Company Performance - EchoStar reported a quarterly loss of $1.06 per share, which was better than the Zacks Consensus Estimate of a loss of $1.12, but worse than a loss of $0.76 per share a year ago [1] - The company achieved an earnings surprise of +5.36% for the quarter, having previously reported a loss of $0.71 per share against an expectation of $0.9 per share, resulting in a surprise of +21.11% [2] - Revenues for the quarter were $3.72 billion, missing the Zacks Consensus Estimate by 2.87%, and down from $3.95 billion year-over-year [3] Stock Performance - EchoStar shares have increased by approximately 42.3% since the beginning of the year, significantly outperforming the S&P 500's gain of 7.8% [4] - The current consensus EPS estimate for the upcoming quarter is -$1.29 on revenues of $3.82 billion, and for the current fiscal year, it is -$4.30 on revenues of $15.4 billion [8] Industry Outlook - The Satellite and Communication industry, to which EchoStar belongs, is currently ranked in the bottom 31% of over 250 Zacks industries, indicating potential challenges ahead [9] - Telesat, another company in the same industry, is expected to report a quarterly loss of $0.69 per share, reflecting a year-over-year change of +76%, with revenues anticipated to be $79.05 million, down 29.1% from the previous year [10][11]

分组1 - Ares Management reported quarterly earnings of $1.03 per share, missing the Zacks Consensus Estimate of $1.11 per share, but showing an increase from $0.99 per share a year ago, resulting in an earnings surprise of -7.21% [1] - The company posted revenues of $1.05 billion for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 1.41%, and compared to year-ago revenues of $786.5 million [2] - Ares Management shares have increased approximately 4.8% since the beginning of the year, while the S&P 500 has gained 7.8% [3] 分组2 - The current consensus EPS estimate for the coming quarter is $1.14 on revenues of $1.08 billion, and for the current fiscal year, it is $5.12 on revenues of $4.78 billion [7] - The Zacks Industry Rank for Financial - Investment Management is currently in the top 19% of over 250 Zacks industries, indicating a favorable outlook for the industry [8]

Core Insights - BrightSpring Health Services, Inc. (BTSG) reported quarterly earnings of $0.22 per share, exceeding the Zacks Consensus Estimate of $0.19 per share, and showing a significant increase from $0.10 per share a year ago, resulting in an earnings surprise of +15.79% [1] - The company achieved revenues of $3.15 billion for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 5.40%, and up from $2.73 billion in the same quarter last year [2] - BrightSpring Health Services has outperformed the S&P 500, with shares increasing approximately 21.3% since the beginning of the year compared to the S&P 500's gain of 7.8% [3] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $0.28 on revenues of $3.16 billion, and for the current fiscal year, it is $0.90 on revenues of $12.29 billion [7] - The estimate revisions trend for BrightSpring Health Services was favorable ahead of the earnings release, leading to a Zacks Rank 2 (Buy) for the stock, indicating expected outperformance in the near future [6] Industry Context - The Medical Services industry, to which BrightSpring belongs, is currently ranked in the top 35% of over 250 Zacks industries, suggesting a positive outlook for stocks within this sector [8]

Company Performance - Linde reported quarterly earnings of $4.09 per share, exceeding the Zacks Consensus Estimate of $4.03 per share, and up from $3.85 per share a year ago, representing an earnings surprise of +1.49% [1] - The company posted revenues of $8.5 billion for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 1.70%, compared to revenues of $8.27 billion in the same quarter last year [2] - Linde has surpassed consensus EPS estimates in all four of the last quarters, but has only topped consensus revenue estimates once during the same period [2] Stock Performance - Linde shares have increased approximately 9.9% since the beginning of the year, outperforming the S&P 500's gain of 7.8% [3] - The stock's immediate price movement will largely depend on management's commentary during the earnings call and future earnings expectations [3][4] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $4.21 on revenues of $8.52 billion, and for the current fiscal year, it is $16.42 on revenues of $33.55 billion [7] - The estimate revisions trend for Linde was unfavorable prior to the earnings release, resulting in a Zacks Rank 4 (Sell) for the stock, indicating expected underperformance in the near future [6] Industry Context - The Chemical - Specialty industry, to which Linde belongs, is currently ranked in the bottom 30% of over 250 Zacks industries, suggesting that the industry outlook may negatively impact stock performance [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]

分组1 - IGM Biosciences, Inc. reported quarterly earnings of $1.58 per share, exceeding the Zacks Consensus Estimate of a loss of $0.3 per share, and showing a significant improvement from a loss of $0.79 per share a year ago, resulting in an earnings surprise of +626.67% [1] - The company posted revenues of $143.62 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 4,388.22%, compared to revenues of $1.25 million in the same quarter last year [2] - IGM Biosciences has surpassed consensus EPS estimates two times over the last four quarters, while also topping consensus revenue estimates twice during the same period [2] 分组2 - The stock has underperformed significantly, losing about 79.4% since the beginning of the year, while the S&P 500 has gained 8.2% [3] - The current consensus EPS estimate for the upcoming quarter is -$0.31 on revenues of $3.21 million, and for the current fiscal year, it is -$1.65 on revenues of $1.75 million [7] - The Zacks Industry Rank for Medical - Biomedical and Genetics is currently in the bottom 41% of over 250 Zacks industries, indicating potential challenges for stocks in this sector [8]

Group 1 - Nexa Resources S.A. reported quarterly earnings of $0.11 per share, exceeding the Zacks Consensus Estimate of a loss of $0.05 per share, representing an earnings surprise of +320.00% [1] - The company posted revenues of $708.42 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 7.36%, although this is a decrease from year-ago revenues of $736.3 million [2] - Over the last four quarters, Nexa Resources has surpassed consensus EPS estimates two times and topped consensus revenue estimates two times [2] Group 2 - The stock has underperformed, losing about 46.1% since the beginning of the year, compared to the S&P 500's gain of 8.2% [3] - The company's earnings outlook is crucial for investors, as it includes current consensus earnings expectations for upcoming quarters and any recent changes to these expectations [4] - The current consensus EPS estimate for the coming quarter is $0.08 on revenues of $699.31 million, and for the current fiscal year, it is $0.09 on revenues of $2.7 billion [7] Group 3 - The Zacks Industry Rank indicates that the Mining - Miscellaneous sector is currently in the bottom 31% of over 250 Zacks industries, suggesting potential underperformance compared to higher-ranked industries [8] - The estimate revisions trend for Nexa Resources was unfavorable ahead of the earnings release, resulting in a Zacks Rank 4 (Sell) for the stock, indicating expected underperformance in the near future [6]

Core Viewpoint - Workiva (WK) reported quarterly earnings of $0.19 per share, significantly exceeding the Zacks Consensus Estimate of $0.05 per share, marking an earnings surprise of +280.00% [1] - The company also posted revenues of $215.19 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 2.97% and showing a year-over-year increase from $177.5 million [2] Financial Performance - Workiva's earnings of $0.19 per share represent an increase from $0.16 per share a year ago, indicating growth in profitability [1] - The company has surpassed consensus EPS estimates two times over the last four quarters and has topped consensus revenue estimates four times during the same period [2] Stock Performance - Workiva shares have declined approximately 39.3% since the beginning of the year, contrasting with the S&P 500's gain of 8.2% [3] - The current Zacks Rank for Workiva is 3 (Hold), suggesting that the shares are expected to perform in line with the market in the near future [6] Future Outlook - The consensus EPS estimate for the upcoming quarter is $0.32 on revenues of $218.31 million, while the estimate for the current fiscal year is $1.04 on revenues of $865.7 million [7] - The outlook for the Internet - Software industry, where Workiva operates, is currently in the top 30% of Zacks industries, indicating a favorable environment for potential stock performance [8]

Core Viewpoint - ICF International reported quarterly earnings of $1.66 per share, exceeding the Zacks Consensus Estimate of $1.63 per share, but down from $1.69 per share a year ago, indicating a slight decline in year-over-year earnings performance [1][2] Financial Performance - The company achieved revenues of $476.16 million for the quarter ended June 2025, which fell short of the Zacks Consensus Estimate by 0.45% and decreased from $512.03 million in the same quarter last year [2] - Over the last four quarters, ICF has surpassed consensus EPS estimates four times, but has only topped consensus revenue estimates once [2] Stock Performance - ICF shares have declined approximately 30.6% since the beginning of the year, contrasting with the S&P 500's gain of 8.2% [3] - The current Zacks Rank for ICF is 3 (Hold), suggesting that the stock is expected to perform in line with the market in the near future [6] Earnings Outlook - The consensus EPS estimate for the upcoming quarter is $1.70, with projected revenues of $472.53 million, while the estimate for the current fiscal year is $6.92 on $1.9 billion in revenues [7] - The trend of earnings estimate revisions for ICF was mixed prior to the earnings release, which may influence future stock performance [6] Industry Context - The Government Services industry, to which ICF belongs, is currently ranked in the top 5% of over 250 Zacks industries, indicating a favorable outlook compared to lower-ranked industries [8]